Skip to main content
Peter Marks, MD, Hematology, New Haven, CT

Peter Wayne Marks MD

Hematology•New Haven, CT

Associate Professor of Medicine, Yale University

Join to View Full Profile

  • 800 Howard AveYale Physicians BldgNew Haven, CT 06519

  • Phone+1 203-785-2140

  • Fax+1 203-785-6414

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 1 invite waiting!
  • Read the latest clinical news, personalized to your specialty.
Join DoximityAlready have an account?

Summary

  • Dr. Peter Marks, MD is a hematologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut, New Jersey, and Massachusetts. He is an Associate Professor of Medicine at Yale University.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1996
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1991 - 1993
  • New York University School of Medicine
    New York University School of MedicineClass of 1991

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1992 - 2027
  • NJ State Medical License
    NJ State Medical License 2004 - 2027
  • CT State Medical License
    CT State Medical License 2006 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • CAR-T Warning for Secondary Malignancies: Warranted or Not?
    CAR-T Warning for Secondary Malignancies: Warranted or Not?January 5th, 2025
  • FDA Panel OKs New COVID Vaccine for Fall
    FDA Panel OKs New COVID Vaccine for FallJune 14th, 2024
  • $3.5M Gene Therapy for Hemophilia Gets FDA Approval
    $3.5M Gene Therapy for Hemophilia Gets FDA ApprovalNovember 22nd, 2022
  • Join now to see all

Dr. Peter Marks, Dr. Peter Marks, MD, Dr. P Marks, Dr. Peter Wayne Marks